<DOC>
	<DOCNO>NCT02739581</DOCNO>
	<brief_summary>The patient randomize two group 1 . Endoscopic Variceal Ligation Non Selective Beta Blocker 2 . Placebo Endoscopic Variceal Ligation</brief_summary>
	<brief_title>Efficacy Safety Endoscopic Variceal Ligation ( EVL ) Versus EVL Plus Non-selective B-blockers ( NSBB ) For Prevention Variceal Rebleed Non-bleed Related Complications Patients With Advanced Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>Patients 18 80 year old . Clinical criterion and/or analytical , ultrasound and/or liver biopsy consistent diagnosis liver cirrhosis . Endoscopic Diagnosis esophageal variceal bleed within 5 day prior study inclusion . Written inform consent participate study . Child C status , CTP &gt; 10 Pregnancy lactation Serum Creatinine &gt; 2 mg/dl Bleeding due gastric varix . Active infection recent infection &lt; 2 week Presence hepatocellular carcinoma portal vein thrombosis Active alcoholism Pregnancy HIV infection Severe heart , respiratory contraindication beta blocker ( severe chronic obstructive pulmonary disease , severe asthma , severe insulindependent diabetes mellitus , Brady arrhythmia ) Not give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>